Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 3
258
Views
10
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the rat

, , , , , & show all
Pages 198-211 | Received 05 Sep 2010, Accepted 14 Oct 2010, Published online: 11 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuzhu Zhang, Jingjing Wu, Yue Zhou, Yulian Yin & Hongfeng Chen. (2018) Effects of psoralen on the pharmacokinetics of anastrozole in rats. Pharmaceutical Biology 56:1, pages 433-439.
Read now

Articles from other publishers (9)

Peili Li, Yasutaka Kurata, Fikri Taufiq, Masanari Kuwabara, Haruaki Ninomiya, Katsumi Higaki, Motokazu Tsuneto, Yasuaki Shirayoshi, Miguel A. Lanaspa & Ichiro Hisatome. (2022) Kv1.5 channel mediates monosodium urate-induced activation of NLRP3 inflammasome in macrophages and arrhythmogenic effects of urate on cardiomyocytes. Molecular Biology Reports 49:7, pages 5939-5952.
Crossref
Sofia Parrasia, Andrea Rossa, Tatiana Varanita, Vanessa Checchetto, Riccardo De Lorenzi, Mario Zoratti, Cristina Paradisi, Paolo Ruzza, Andrea Mattarei, Ildikò Szabò & Lucia Biasutto. (2021) An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors. Pharmaceuticals 14:2, pages 129.
Crossref
Roberta Peruzzo, Andrea Mattarei, Michele Azzolini, Katrin Anne Becker-Flegler, Matteo Romio, Giovanni Rigoni, Andrea Carrer, Lucia Biasutto, Sofia Parrasia, Stephanie Kadow, Antonella Managò, Andrea Urbani, Andrea Rossa, Gianpietro Semenzato, Maria Eugenia Soriano, Livio Trentin, Syed Ahmad, Michael Edwards, Erich Gulbins, Cristina Paradisi, Mario Zoratti, Luigi Leanza & Ildikò Szabò. (2020) Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family. Redox Biology 37, pages 101705.
Crossref
Sara Moreno-Estar, Sofía Serrano, Marycarmen Arévalo-Martínez, Pilar Cidad, José Ramón López-López, Mercedes Santos, M. Teresa Pérez-Garcia & F. Javier Arias. (2020) Elastin-like recombinamer-based devices releasing Kv1.3 blockers for the prevention of intimal hyperplasia: An in vitro and in vivo study. Acta Biomaterialia 115, pages 264-274.
Crossref
Li Yang, Ying-li Yu, Li-yuan Cheng, Pan-yang Zhang, Yue Zhang & Kun Zhou. (2020) The Accumulation of Psoralen Contributes to Its Hepatotoxicity Revealed by Pharmacokinetic and Toxicokinetic Study after Repeated Administration. ACS Omega 5:13, pages 7307-7315.
Crossref
Luigi Leanza, Matteo Romio, Katrin Anne Becker, Michele Azzolini, Livio Trentin, Antonella Managò, Elisa Venturini, Angela Zaccagnino, Andrea Mattarei, Luca Carraretto, Andrea Urbani, Stephanie Kadow, Lucia Biasutto, Veronica Martini, Filippo Severin, Roberta Peruzzo, Valentina Trimarco, Jan-Hendrik Egberts, Charlotte Hauser, Andrea Visentin, Gianpietro Semenzato, Holger Kalthoff, Mario Zoratti, Erich Gulbins, Cristina Paradisi & Ildiko Szabo. (2017) Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo. Cancer Cell 31:4, pages 516-531.e10.
Crossref
Richard J. Lewis, Irina Vetter, Fernanda C. Cardoso, Marco Inserra & Glenn King. 2014. Ion Channel Drug Discovery. Ion Channel Drug Discovery 297 319 .
Ying Peng, Kui Lu, Zichen Li, Yaodong Zhao, Yiping Wang, Bin Hu, Pengfei Xu, Xiaolei Shi, Bin Zhou, Michael Pennington, K. George Chandy & Yamei Tang. (2014) Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro-Oncology 16:4, pages 528-539.
Crossref
Jun Wang & Ming Xiang. (2013) Targeting Potassium Channels K v1.3 and K C a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment? . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:5, pages 515-528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.